Therapeutic targets for amyloid diseases

Therapeutic targets for amyloid diseases, such as Alzheimer's or amyloidosis, focus on the buildup of abnormal proteins called amyloids in the body. These proteins can disrupt normal function, leading to serious health issues. Researchers aim to develop treatments that either prevent the formation of these proteins, help break them down, or improve the body’s ability to clear them out. By targeting these pathways, the goal is to slow disease progression, improve symptoms, and enhance the quality of life for affected individuals.